Kenichi Sudo
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Surgery 26
- Cardiac and Coronary Surgery Techniques 9
- Cardiac Structural Anomalies and Repair 6
- Co-authors
- Kazumasa Shimizu (7 shared papers)Osamu Okazaki (16 shared papers)Tadashi Yamamoto (1 shared paper)Shuichi Ikeyama (1 shared paper)Takashi Fujita (1 shared paper)Hideo Hakusui (6 shared papers)Mitsuaki Yamaoka (1 shared paper)Naotoshi Nakashima (1 shared paper)
- Journals
- The Annals of Thoracic Surgery (11 papers)Drug Metabolism and Disposition (6 papers)Xenobiotica (5 papers)Biomedical Chromatography (4 papers)Chemical and Pharmaceutical Bulletin (3 papers)
- Partner nations
- JapanGermanyUnited Kingdom
In The Last Decade
Kenichi Sudo
99 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 292
- Oncology 339
- Biomaterials 177
- Biomedical Engineering 471
- Cardiology and Cardiovascular Medicine 183
Countries citing papers authored by Kenichi Sudo
This map shows the geographic impact of Kenichi Sudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Sudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Sudo more than expected).
Fields of papers citing papers by Kenichi Sudo
This network shows the impact of papers produced by Kenichi Sudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Sudo. The network helps show where Kenichi Sudo may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenichi Sudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 203 | |
| 2 | Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. | 1993 | 147 |
| 3 | 1997 | 145 | |
| 4 | 1993 | 108 | |
| 5 | 2000 | 84 | |
| 6 | 2009 | 65 | |
| 7 | 1998 | 64 | |
| 8 | 2010 | 62 | |
| 9 | 2008 | 59 | |
| 10 | 2007 | 58 | |
| 11 | 1987 | 51 | |
| 12 | 1985 | 39 | |
| 13 | 2008 | 34 | |
| 14 | 2007 | 31 | |
| 15 | 2009 | 29 | |
| 16 | 2010 | 27 | |
| 17 | 1986 | 27 | |
| 18 | 2009 | 26 | |
| 19 | 1986 | 23 | |
| 20 | 1981 | 20 |
About Kenichi Sudo
Kenichi Sudo is a scholar working on Surgery, Molecular Biology, Pharmacology, Oncology and Biomedical Engineering, having authored 102 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (15 papers), Lignin and Wood Chemistry (9 papers), Cardiac and Coronary Surgery Techniques (9 papers), Cardiac Valve Diseases and Treatments (8 papers), Aortic Disease and Treatment Approaches (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cardiac Structural Anomalies and Repair (6 papers). The work is most often cited by research in Pharmacology (292 citations), Oncology (339 citations), Biomaterials (177 citations), Biomedical Engineering (471 citations) and Cardiology and Cardiovascular Medicine (183 citations). Kenichi Sudo has collaborated with scholars based in Japan, Germany and United Kingdom. Frequent co-authors include Kazumasa Shimizu, Osamu Okazaki, Tadashi Yamamoto, Shuichi Ikeyama, Takashi Fujita, Hideo Hakusui, Mitsuaki Yamaoka, Naotoshi Nakashima, Hiroshi Masumoto and Yukio Kato. Their work appears in journals such as The Annals of Thoracic Surgery, Drug Metabolism and Disposition, Xenobiotica, Biomedical Chromatography and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.